Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 3257

1.

Antibody landscapes after influenza virus infection or vaccination.

Fonville JM, Wilks SH, James SL, Fox A, Ventresca M, Aban M, Xue L, Jones TC, Le NM, Pham QT, Tran ND, Wong Y, Mosterin A, Katzelnick LC, Labonte D, Le TT, van der Net G, Skepner E, Russell CA, Kaplan TD, Rimmelzwaan GF, Masurel N, de Jong JC, Palache A, Beyer WE, Le QM, Nguyen TH, Wertheim HF, Hurt AC, Osterhaus AD, Barr IG, Fouchier RA, Horby PW, Smith DJ.

Science. 2014 Nov 21;346(6212):996-1000. doi: 10.1126/science.1256427.

PMID:
25414313
[PubMed - indexed for MEDLINE]
2.

Immunology. Charting the life-course epidemiology of influenza.

Lessler J.

Science. 2014 Nov 21;346(6212):919-20. doi: 10.1126/science.aaa0613. No abstract available.

PMID:
25414291
[PubMed - indexed for MEDLINE]
3.

Immunogenicity of avian influenza A/Anhui/01/2005(H5N1) vaccine with MF59 adjuvant: a randomized clinical trial.

Belshe RB, Frey SE, Graham IL, Anderson EL, Jackson LA, Spearman P, Edupuganti S, Mulligan MJ, Rouphael N, Winokur P, Dolor RJ, Woods CW, Walter EB, Chen WH, Turley C, Edwards KM, Creech CB, Hill H, Bellamy AR; National Institute of Allergy and Infectious Diseases–Funded Vaccine and Treatment Evaluation Units.

JAMA. 2014 Oct 8;312(14):1420-8. doi: 10.1001/jama.2014.12609.

PMID:
25291578
[PubMed - indexed for MEDLINE]
4.

Serological responses to an avian influenza A/H7N9 vaccine mixed at the point-of-use with MF59 adjuvant: a randomized clinical trial.

Mulligan MJ, Bernstein DI, Winokur P, Rupp R, Anderson E, Rouphael N, Dickey M, Stapleton JT, Edupuganti S, Spearman P, Ince D, Noah DL, Hill H, Bellamy AR; DMID 13-0032 H7N9 Vaccine Study Group.

JAMA. 2014 Oct 8;312(14):1409-19. doi: 10.1001/jama.2014.12854.

PMID:
25291577
[PubMed - indexed for MEDLINE]
5.

Coinfection with Streptococcus pneumoniae modulates the B cell response to influenza virus.

Wolf AI, Strauman MC, Mozdzanowska K, Whittle JR, Williams KL, Sharpe AH, Weiser JN, Caton AJ, Hensley SE, Erikson J.

J Virol. 2014 Oct;88(20):11995-2005. doi: 10.1128/JVI.01833-14. Epub 2014 Aug 6.

PMID:
25100838
[PubMed - indexed for MEDLINE]
6.

Chimeric influenza-virus-like particles containing the porcine reproductive and respiratory syndrome virus GP5 protein and the influenza virus HA and M1 proteins.

Xue C, Wang W, Liu Q, Miao Z, Liu K, Shen H, Lv L, Li X, Chen X, Cao Y.

Arch Virol. 2014 Nov;159(11):3043-51. doi: 10.1007/s00705-014-2178-0. Epub 2014 Jul 27.

PMID:
25064513
[PubMed - indexed for MEDLINE]
7.

Efficacy of a high-growth reassortant H1N1 influenza virus vaccine against the classical swine H1N1 subtype influenza virus in mice and pigs.

Wen F, Yu H, Yang FR, Huang M, Yang S, Zhou YJ, Li ZJ, Tong GZ.

Arch Virol. 2014 Nov;159(11):2957-67. doi: 10.1007/s00705-014-2151-y. Epub 2014 Jun 24.

PMID:
24957653
[PubMed - indexed for MEDLINE]
8.

Influenza hemagglutinin stem-fragment immunogen elicits broadly neutralizing antibodies and confers heterologous protection.

Mallajosyula VV, Citron M, Ferrara F, Lu X, Callahan C, Heidecker GJ, Sarma SP, Flynn JA, Temperton NJ, Liang X, Varadarajan R.

Proc Natl Acad Sci U S A. 2014 Jun 24;111(25):E2514-23. doi: 10.1073/pnas.1402766111. Epub 2014 Jun 9.

PMID:
24927560
[PubMed - indexed for MEDLINE]
Free Article
9.

Characterization of recombinant influenza A virus as a vector expressing respiratory syncytial virus fusion protein epitopes.

Zhang P, Gu H, Bian C, Liu N, Li Z, Duan Y, Zhang S, Wang X, Yang P.

J Gen Virol. 2014 Sep;95(Pt 9):1886-91. doi: 10.1099/vir.0.064105-0. Epub 2014 Jun 9.

PMID:
24914066
[PubMed - indexed for MEDLINE]
10.

An alphavirus-based adjuvant enhances serum and mucosal antibodies, T cells, and protective immunity to influenza virus in neonatal mice.

Khalil SM, Tonkin DR, Snead AT, Parks GD, Johnston RE, White LJ.

J Virol. 2014 Aug;88(16):9182-96. doi: 10.1128/JVI.00327-14. Epub 2014 Jun 4.

PMID:
24899195
[PubMed - indexed for MEDLINE]
11.

Inactivated vaccine with adjuvants consisting of pattern recognition receptor agonists confers protection against avian influenza viruses in chickens.

Tang Y, Lu J, Wu P, Liu Z, Tian Z, Zha G, Chen H, Wang Q, Wang Q, Hou F, Kang SM, Hou J.

Vet Microbiol. 2014 Aug 6;172(1-2):120-8. doi: 10.1016/j.vetmic.2014.05.007. Epub 2014 May 13.

PMID:
24894132
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Rituximab impairs immunoglobulin (Ig)M and IgG (subclass) responses after influenza vaccination in rheumatoid arthritis patients.

Westra J, van Assen S, Wilting KR, Land J, Horst G, de Haan A, Bijl M.

Clin Exp Immunol. 2014 Oct;178(1):40-7. doi: 10.1111/cei.12390.

PMID:
24889761
[PubMed - indexed for MEDLINE]
13.

PapMV nanoparticles improve mucosal immune responses to the trivalent inactivated flu vaccine.

Rioux G, Mathieu C, Russell A, Bolduc M, Laliberté-Gagné ME, Savard P, Leclerc D.

J Nanobiotechnology. 2014 May 3;12:19. doi: 10.1186/1477-3155-12-19.

PMID:
24885884
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Responses to A(H1N1)pdm09 influenza vaccines in participants previously vaccinated with seasonal influenza vaccine: a randomized, observer-blind, controlled study.

Roy-Ghanta S, Van der Most R, Li P, Vaughn DW.

J Infect Dis. 2014 Nov 1;210(9):1419-30. doi: 10.1093/infdis/jiu284. Epub 2014 May 26.

PMID:
24864125
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Protective efficacy of intranasally administered bivalent live influenza vaccine and immunological mechanisms underlying the protection.

Pyo HM, Zhou Y.

Vaccine. 2014 Jun 24;32(30):3835-42. doi: 10.1016/j.vaccine.2014.04.065. Epub 2014 May 14.

PMID:
24837774
[PubMed - indexed for MEDLINE]
16.

Potency of an inactivated influenza vaccine prepared from A/duck/Hong Kong/960/1980 (H6N2) against a challenge with A/duck/Vietnam/OIE-0033/2012 (H6N2) in mice.

Nishi T, Sakoda Y, Okamatsu M, Kida H.

Arch Virol. 2014 Oct;159(10):2567-74. doi: 10.1007/s00705-014-2107-2. Epub 2014 May 14.

PMID:
24824346
[PubMed - indexed for MEDLINE]
17.

African green monkeys recapitulate the clinical experience with replication of live attenuated pandemic influenza virus vaccine candidates.

Matsuoka Y, Suguitan A Jr, Orandle M, Paskel M, Boonnak K, Gardner DJ, Feldmann F, Feldmann H, Marino M, Jin H, Kemble G, Subbarao K.

J Virol. 2014 Jul;88(14):8139-52. doi: 10.1128/JVI.00425-14. Epub 2014 May 7.

PMID:
24807726
[PubMed - indexed for MEDLINE]
18.

Protective efficacy of a bacterially produced modular capsomere presenting M2e from influenza: extending the potential of broadly cross-protecting epitopes.

Wibowo N, Hughes FK, Fairmaid EJ, Lua LH, Brown LE, Middelberg AP.

Vaccine. 2014 Jun 17;32(29):3651-5. doi: 10.1016/j.vaccine.2014.04.062. Epub 2014 May 2.

PMID:
24795225
[PubMed - indexed for MEDLINE]
19.

Efficacy of a non-updated, Matrix-C-based equine influenza subunit-tetanus vaccine following Florida sublineage clade 2 challenge.

Pouwels HG, Van de Zande SM, Horspool LJ, Hoeijmakers MJ.

Vet Rec. 2014 Jun 21;174(25):633. doi: 10.1136/vr.101993. Epub 2014 May 2.

PMID:
24795071
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

[Immunization with live attenuated A/H5N1 vaccine protects guinea pigs from reinfection].

Sergeeva MV, Kuznetsov VV, Kas'ianenko MA, Shaldzhian AA, Repko IA, Potapchuk MV, Romanova IuR, Tsybalova LM.

Vopr Virusol. 2013 Nov-Dec;58(6):36-9. Russian.

PMID:
24772645
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk